There are many types of life science companies involved in the research and development (R&D) of new drugs and medical devices, but they generally fall into two camps, biotechnology firms that develop the drug or device, and service organizations who help bring those products to market.
The exposures that biotechs and service organizations face will evolve throughout the R&DĀ process, and how quickly each company moves through this journey will depend on theirĀ individual product but can take anywhere from a few months to a few years.
CFC has outlined the phases of the R&D process to help you talk to your life science clients about the key exposures they face as they discover, develop and test their products.
Click here to download the full infographic below.
Source: www.cfcunderwriting.com